vTv Therapeutics's market cap is currently $70.84M. The company's EPS TTM is $-0.92; its P/E ratio is ―; vTv Therapeutics is scheduled to report earnings on August 12, 2025, and the estimated EPS forecast is $-0.98. See an overview of income statement, balance sheet, and cash flow financials.
